|
Coumarin | Model/cells | Effects | Reference(s) |
|
IMP | Arsenic trioxide-induced toxicity in H9c2 cells | IMP-attenuated ROS generation, cytotoxicity, and apoptosis triggered Nrf2 activation. | [76] |
IgE-mediated allergic responses in RBL-2H3 cells | IMP inhibited mast cell degranulation; suppressed NF-κB, p38, JNK, and ERK MAPKs; and increased Nrf2 nuclear translocation. | [77] |
|
Urolithin B | LPS-induced BV2 microglial cells | Urolithin B reduced ROS production, NADPH oxidase expression, NF-κB, ERK, and JNK and increased AMPK phosphorylation, Nrf2, and HO-1. | [92] |
|
Urolithin A | Senescent human skin fibroblasts | Urolithin A increased type I collagen expression, reduced intracellular ROS, abolished MMP-1 expression, and activated Nrf2/ARE signaling. | [103] |
LPS-induced Caco2 and HT-29 cells | Urolithin A activated aryl hydrocarbon receptor- (AhR-) Nrf2-dependent pathways. | [104] |
|
Scopoletin | Rotenone-stimulated SH-SY5Y cells | Scopoletin prevented oxidative stress and apoptosis and activated Nrf2 signaling. | [122] |
|
Daphnetin | Oleic acid-induced HepG2 cells | Daphnetin decreased CYP2E1 and CYP4A expression, promoted glucose uptake and insulin sensitivity, and enhanced PI3K/Akt and Nrf2 signaling. | [133] |
Arsenic-induced human lung epithelial cells | Daphnetin reduced ROS, JNK, ERK, Keap1, and apoptosis and activated Nrf2/ARE pathway. | [134] |
HG-induced human glomerular mesangial cells | Daphnetin reduced ROS production; attenuated the release of IL-1β, IL-6, and TNF-α via suppression of NF-κB pathway; inhibited the expression Keap1; and upregulated Nrf2. | [135] |
Oxygen-glucose deprivation/reoxygenation-induced hippocampal neurons | Daphnetin inhibited oxidative stress and cell apoptosis and enhanced the nuclear translocation of Nrf2 and HO-1 expression. | [136] |
t-BHP-induced RAW264.7 cells | Daphnetin suppressed ROS, inhibited cytochrome c release and NLRP3 inflammasome activation, and upregulated Nrf2 nuclear translocation along with Keap1 protein downregulation. | [137] |
|
Esculin | EK 293 and RAW264.7 cells | Esculin suppressed ROS production and activated Nrf2/ARE signaling. | [148] |
|
Esculetin | NB4 leukemia cells | Esculetin increased the nuclear translocation of Nrf2. | [164] |
HG-induced rat mesangial cell line HBZY-1 | Esculetin suppressed ROS production and IL-6 expression and activated Nrf2. | [166] |
H2O2-induced C2C12 myoblasts | Esculetin suppressed ROS production and activated the Nrf2/NQO1 pathway. | [167] |
Pancreatic carcinoma cells (PANC-1) | Esculetin increased Nrf2 and NQO1 gene expression and Nrf2 nuclear accumulation. | [168] |
|
| H2O2-induced HepG2 cells | Esculetin activated Nrf2/NQO1 pathway | [169] |
UMB | HG-induced mesangial cells | UMB suppressed ROS production and activated Nrf2. | [166] |
MG-induced HepG2 cells | UMB abolished ROS generation and increased Nrf2 expression, effects inhibited by Nrf2 depletion. | [181] |
|
Fraxetin | Vascular smooth muscle cells | Fraxetin increased the expression of HO-1 and Nrf2. | [195] |
HaCaT human keratinocytes | Fraxetin reduced ROS and upregulated Akt, AMPK, HO-1, and Nrf2. | [194] |
|
Fraxin | t-BHP-induced HepG2 cells | Fraxin inhibited t-BHP-induced cytotoxicity and ROS generation through Nrf2-dependent HO-1 expression. | [198] |
|
Wedelolactone | t-BHP-induced adrenal pheochromocytoma cells | A wedelolactone-rich extract prevented apoptosis and activated Nrf2/ARE pathway. | [219] |
|
Osthole | LPS-stimulated BV2 mouse microglia | Osthole suppressed NF-κB, IL-1β, IL-6, and TNF-α and upregulated Nrf2/HO-1 signaling | [245] |
LPS-stimulated mesangial cells | Osthole inhibited ROS generation, MCP-1 secretion, and NF-κB activation and upregulated Nrf2. | [248] |
|
Hydrangenol | LPS-stimulated BV2 microglial cells | Hydrangenol attenuated NO production and iNOS expression by inhibiting NF-κB activation and stimulated Nrf2/HO-1 signaling pathway. | [250] |
|
Isoimperatorin | Aflatoxin B1-inducible cytotoxicity in H4IIE | Isoimperatorin activated Nrf2/ARE and GST-α and suppressed CYP1A expression. | [256] |
|